Clinical Trials Logo

Clinical Trial Summary

TS ELiOT is a stepped-wedge, cluster randomized trial assessing the effect of a next-generation sequencing-based strategy on rifampin-resistant tuberculosis management and patient outcomes.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05553236
Study type Interventional
Source University of California, San Francisco
Contact John Z Metcalfe, MD, PhD
Phone +14152068314
Email john.metcalfe@ucsf.edu
Status Not yet recruiting
Phase N/A
Start date October 28, 2024
Completion date January 2027

See also
  Status Clinical Trial Phase
Recruiting NCT05017324 - Sequencing Mycobacteria and Algorithm-determined Resistant Tuberculosis Treatment Trial N/A
Active, not recruiting NCT04179500 - A Trial to Evaluate the Male Reproductive Safety of Pretomanid in Adult Male Participants With Drug Resistant Pulmonary Tuberculosis Volunteers Phase 2
Recruiting NCT06224036 - Clinical Study of JDB0131 Benzenesulfonate Tablets in Patients With Drug-sensitive Pulmonary Tuberculosis Phase 2
Completed NCT02234908 - Rewards for Tuberculosis Contact Screening N/A
Completed NCT02236078 - Brief Bactericidal Activity of Anti-Tuberculosis Drugs Phase 1
Completed NCT04147676 - Evaluation of Centralised TB Assay Solutions
Completed NCT04493671 - Evaluate Safety, Tolerability, PK of TBAJ-876 in Healthy Adults Phase 1
Completed NCT03338621 - Trial to Evaluate the Efficacy, Safety and Tolerability of BPaMZ in Drug-Sensitive (DS-TB) Adult Patients and Drug-Resistant (DR-TB) Adult Patients Phase 2/Phase 3
Completed NCT05526911 - A Phase 1, Drug-Drug Interaction Study of TBAJ-876 in Healthy Adults Phase 1
Completed NCT03266003 - An Evaluation of Traditional Directly Observed Therapy (DOT) and Electronic DOT for TB Treatment N/A
Completed NCT04119375 - Behavior Change and Digital Health Interventions for Improved TB Treatment Outcomes N/A